
|Videos|July 20, 2021
The Future of Telemedicine as the COVID-19 Pandemic Wanes
Mary Reed, DrPH, research scientist at Kaiser Permanente, discussed what changes would be necessary to continue providing quality virtual health care to patients with diabetes.
Advertisement
Pharmacy Times interviewed Mary Reed, DrPH, research scientist at Kaiser Permanente, on the subject of her 2021 ADA conference session, "Reimagining Diabetes Care in the Virtual World."
In this discussion, Reed focuses on what advances need to be made to provide patients with quality virtual health care even as the pandemic wanes. She urges practitioners not to abandon the telemedicine methods that were implemented due to COVID-19, and emphasized that patients who have experience with telemedicine are far more likely to want to use it again.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
4
New CKD Outcome Set Tells Pharmacists What to Measure
5





































































































